List of Tables
Table 1. Global Gefitinib Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Gefitinib Tablets Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Gefitinib Tablets Market Competitive Situation by Manufacturers in 2024
Table 4. Global Gefitinib Tablets Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Gefitinib Tablets Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Gefitinib Tablets Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Gefitinib Tablets Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Gefitinib Tablets Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Gefitinib Tablets, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Gefitinib Tablets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gefitinib Tablets, Product Type & Application
Table 12. Global Key Manufacturers of Gefitinib Tablets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gefitinib Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gefitinib Tablets as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gefitinib Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Gefitinib Tablets Sales by Region (2020-2025) & (K Units)
Table 18. Global Gefitinib Tablets Sales Market Share by Region (2020-2025)
Table 19. Global Gefitinib Tablets Sales by Region (2026-2031) & (K Units)
Table 20. Global Gefitinib Tablets Sales Market Share by Region (2026-2031)
Table 21. Global Gefitinib Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Gefitinib Tablets Revenue Market Share by Region (2020-2025)
Table 23. Global Gefitinib Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Gefitinib Tablets Revenue Market Share by Region (2026-2031)
Table 25. North America Gefitinib Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Gefitinib Tablets Sales by Country (2020-2025) & (K Units)
Table 27. North America Gefitinib Tablets Sales by Country (2026-2031) & (K Units)
Table 28. North America Gefitinib Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Gefitinib Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Gefitinib Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Gefitinib Tablets Sales by Country (2020-2025) & (K Units)
Table 32. Europe Gefitinib Tablets Sales by Country (2026-2031) & (K Units)
Table 33. Europe Gefitinib Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Gefitinib Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Gefitinib Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Gefitinib Tablets Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Gefitinib Tablets Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Gefitinib Tablets Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Gefitinib Tablets Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Gefitinib Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Gefitinib Tablets Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Gefitinib Tablets Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Gefitinib Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Gefitinib Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Gefitinib Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Gefitinib Tablets Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Gefitinib Tablets Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Gefitinib Tablets Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Gefitinib Tablets Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Gefitinib Tablets Sales (K Units) by Type (2020-2025)
Table 51. Global Gefitinib Tablets Sales (K Units) by Type (2026-2031)
Table 52. Global Gefitinib Tablets Sales Market Share by Type (2020-2025)
Table 53. Global Gefitinib Tablets Sales Market Share by Type (2026-2031)
Table 54. Global Gefitinib Tablets Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Gefitinib Tablets Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Gefitinib Tablets Revenue Market Share by Type (2020-2025)
Table 57. Global Gefitinib Tablets Revenue Market Share by Type (2026-2031)
Table 58. Global Gefitinib Tablets Price (US$/Unit) by Type (2020-2025)
Table 59. Global Gefitinib Tablets Price (US$/Unit) by Type (2026-2031)
Table 60. Global Gefitinib Tablets Sales (K Units) by Application (2020-2025)
Table 61. Global Gefitinib Tablets Sales (K Units) by Application (2026-2031)
Table 62. Global Gefitinib Tablets Sales Market Share by Application (2020-2025)
Table 63. Global Gefitinib Tablets Sales Market Share by Application (2026-2031)
Table 64. Global Gefitinib Tablets Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Gefitinib Tablets Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Gefitinib Tablets Revenue Market Share by Application (2020-2025)
Table 67. Global Gefitinib Tablets Revenue Market Share by Application (2026-2031)
Table 68. Global Gefitinib Tablets Price (US$/Unit) by Application (2020-2025)
Table 69. Global Gefitinib Tablets Price (US$/Unit) by Application (2026-2031)
Table 70. Qilu Pharmaceutical Company Information
Table 71. Qilu Pharmaceutical Description and Business Overview
Table 72. Qilu Pharmaceutical Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Qilu Pharmaceutical Gefitinib Tablets Product
Table 74. Qilu Pharmaceutical Recent Developments/Updates
Table 75. Sichuan Kelun Pharmaceutical Co.,Ltd. Company Information
Table 76. Sichuan Kelun Pharmaceutical Co.,Ltd. Description and Business Overview
Table 77. Sichuan Kelun Pharmaceutical Co.,Ltd. Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Sichuan Kelun Pharmaceutical Co.,Ltd. Gefitinib Tablets Product
Table 79. Sichuan Kelun Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 80. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Company Information
Table 81. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Description and Business Overview
Table 82. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Gefitinib Tablets Product
Table 84. Jiangsu Hengrui Pharmaceuticals Co.,ltd. Recent Developments/Updates
Table 85. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Company Information
Table 86. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Description and Business Overview
Table 87. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Gefitinib Tablets Product
Table 89. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 90. Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
Table 91. Yangtze River Pharmaceutical (Group) Co., Ltd. Description and Business Overview
Table 92. Yangtze River Pharmaceutical (Group) Co., Ltd. Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Yangtze River Pharmaceutical (Group) Co., Ltd. Gefitinib Tablets Product
Table 94. Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
Table 95. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Company Information
Table 96. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Description and Business Overview
Table 97. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Gefitinib Tablets Product
Table 99. Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 100. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Company Information
Table 101. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Description and Business Overview
Table 102. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Gefitinib Tablets Product
Table 104. Shanghai DESANO Pharmaceuticals Holding Co., Ltd. Recent Developments/Updates
Table 105. NatcoPharma Company Information
Table 106. NatcoPharma Description and Business Overview
Table 107. NatcoPharma Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. NatcoPharma Gefitinib Tablets Product
Table 109. NatcoPharma Recent Developments/Updates
Table 110. AstraZeneca plc Company Information
Table 111. AstraZeneca plc Description and Business Overview
Table 112. AstraZeneca plc Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. AstraZeneca plc Gefitinib Tablets Product
Table 114. AstraZeneca plc Recent Developments/Updates
Table 115. Intelicure Lifesciences Company Information
Table 116. Intelicure Lifesciences Description and Business Overview
Table 117. Intelicure Lifesciences Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Intelicure Lifesciences Gefitinib Tablets Product
Table 119. Intelicure Lifesciences Recent Developments/Updates
Table 120. Weefsel Pharma Company Information
Table 121. Weefsel Pharma Description and Business Overview
Table 122. Weefsel Pharma Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Weefsel Pharma Gefitinib Tablets Product
Table 124. Weefsel Pharma Recent Developments/Updates
Table 125. Taj Pharmaceuticals Company Information
Table 126. Taj Pharmaceuticals Description and Business Overview
Table 127. Taj Pharmaceuticals Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Taj Pharmaceuticals Gefitinib Tablets Product
Table 129. Taj Pharmaceuticals Recent Developments/Updates
Table 130. Saintroy Lifescience Company Information
Table 131. Saintroy Lifescience Description and Business Overview
Table 132. Saintroy Lifescience Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Saintroy Lifescience Gefitinib Tablets Product
Table 134. Saintroy Lifescience Recent Developments/Updates
Table 135. Actiza Pharmaceutical Company Information
Table 136. Actiza Pharmaceutical Description and Business Overview
Table 137. Actiza Pharmaceutical Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Actiza Pharmaceutical Gefitinib Tablets Product
Table 139. Actiza Pharmaceutical Recent Developments/Updates
Table 140. Teva Company Information
Table 141. Teva Description and Business Overview
Table 142. Teva Gefitinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Teva Gefitinib Tablets Product
Table 144. Teva Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Gefitinib Tablets Distributors List
Table 148. Gefitinib Tablets Customers List
Table 149. Gefitinib Tablets Market Trends
Table 150. Gefitinib Tablets Market Drivers
Table 151. Gefitinib Tablets Market Challenges
Table 152. Gefitinib Tablets Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Gefitinib Tablets
Figure 2. Global Gefitinib Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Gefitinib Tablets Market Share by Type: 2024 & 2031
Figure 4. Original Drugs Product Picture
Figure 5. Generic Drugs Product Picture
Figure 6. Global Gefitinib Tablets Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Gefitinib Tablets Market Share by Application: 2024 & 2031
Figure 8. Breast Cancer
Figure 9. Lung Cancer
Figure 10. Other
Figure 11. Global Gefitinib Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Gefitinib Tablets Market Size (2020-2031) & (US$ Million)
Figure 13. Global Gefitinib Tablets Sales (2020-2031) & (K Units)
Figure 14. Global Gefitinib Tablets Average Price (US$/Unit) & (2020-2031)
Figure 15. Gefitinib Tablets Report Years Considered
Figure 16. Gefitinib Tablets Sales Share by Manufacturers in 2024
Figure 17. Global Gefitinib Tablets Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Gefitinib Tablets Players: Market Share by Revenue in Gefitinib Tablets in 2024
Figure 19. Gefitinib Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Gefitinib Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Gefitinib Tablets Sales Market Share by Country (2020-2031)
Figure 22. North America Gefitinib Tablets Revenue Market Share by Country (2020-2031)
Figure 23. United States Gefitinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Gefitinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Gefitinib Tablets Sales Market Share by Country (2020-2031)
Figure 26. Europe Gefitinib Tablets Revenue Market Share by Country (2020-2031)
Figure 27. Germany Gefitinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Gefitinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Gefitinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Gefitinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Gefitinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Gefitinib Tablets Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Gefitinib Tablets Revenue Market Share by Region (2020-2031)
Figure 34. China Gefitinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Gefitinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Gefitinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Gefitinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Gefitinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Gefitinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Gefitinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Gefitinib Tablets Sales Market Share by Country (2020-2031)
Figure 42. Latin America Gefitinib Tablets Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Gefitinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Gefitinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Gefitinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Gefitinib Tablets Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Gefitinib Tablets Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Gefitinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Gefitinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Gefitinib Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Gefitinib Tablets by Type (2020-2031)
Figure 52. Global Revenue Market Share of Gefitinib Tablets by Type (2020-2031)
Figure 53. Global Gefitinib Tablets Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Gefitinib Tablets by Application (2020-2031)
Figure 55. Global Revenue Market Share of Gefitinib Tablets by Application (2020-2031)
Figure 56. Global Gefitinib Tablets Price (US$/Unit) by Application (2020-2031)
Figure 57. Gefitinib Tablets Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
